Impact of the COVID-19 pandemic on obstructive sleep apnea: recommendations for symptom management
Impact of the COVID-19 pandemic on obstructive sleep apnea: recommendations for symptom management
复制标题
DOI：
10.5664/jcsm.8922
复制
发表时间：
2021-03-01
影响因子：
4.3
通讯作者：
Bailes, Sally
中科院分区：
文献类型：
--
作者：
Rizzo, Dorrie;Libman, Eva;Bailes, Sally
研究目的：在当前COVID-19疫情的背景下，我们解决以下重要问题：（1）在睡眠诊所测试暂时不可用或有限的情况下，如何识别患者是否患有可能的OSA？和（2）在适当的诊断和治疗再次变得安全和可用之前，可以建议采取哪些措施来改善睡眠健康？研究方法：作为家庭或实验室检测的替代，基于一项正在进行的更大规模的前瞻性研究，对156名OSA家庭医学患者（88名女性，68名男性;平均年龄57岁）和60名对照参与者（36名女性，24名男性;平均年龄54岁）进行了验证。结果：（1）OSA患者在睡眠症状自评量表（SSC）上报告的失眠、日间症状、睡眠障碍和心理适应不良等症状多于对照组（P < 0.05），而在睡眠质量方面，OSA患者的睡眠质量明显高于对照组（P < 0.05）。
Study Objectives: In the context of the current COVID-19 pandemic situation, we address the following important questions: (1) How can patients be identified for possible OSA while sleep clinic testing is temporarily unavailable or limited? and (2) What measures can be suggested to improve sleep health until proper diagnosis and treatment become safe and available again?Methods: As a proxy for home or in-laboratory testing, validation of a symptom-based measure ofOSA risk is presented, based on an ongoing larger prospective study of 156 family medicine patients with OSA (88 women, 68 men; mean age, 57 years) and 60 control participants (36 women, 24 men; mean age, 54 years) recruited from the community. Participants completed the Sleep Symptom Checklist (SSC) and a range of other self-report measures; primary care patients also underwent a polysomnographic sleep study.Results: Results showed that (1) individuals with OSA reported more symptoms on the SSC related to insomnia, daytime symptoms, sleep disorders, and psychological maladjustment than did the control group (all P